# 2026-19230: California MD's DEA Registration Revoked Without a Hearing

2026-19230, John Ramsay Walters, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-09-21, effective 2026-10-21 (as of 2026-09-28).

- Canonical: https://policyrisk.com/federal-register/2026-19230
- As of: 2026-09-28
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19230
- Title: John Ramsay Walters, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 59797
- Published: 2026-09-21
- Effective: 2026-10-21
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-28

## In one line

California MD's DEA Registration Revoked Without a Hearing

## Summary

Dr. John Ramsay Walters from California lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of May 31, 2026. This means he can’t legally prescribe or dispense controlled drugs anymore, affecting his medical practice and patients.

## Effects PRIA read

- DEA Registration Revoked for Dr. Walters: cost, high. The DEA revoked John Ramsay Walters, M.D.'s Certificate of Registration No. AW8146602, effective October 21, 2026. His DEA registration had expired on May 31, 2026, and he surrendered his California medical license effective December 31, 2025, so he cannot legally prescribe or dispense controlled s…
- Pending Registration Applications Denied: cost, high. The DEA denied any pending applications by John Ramsay Walters, M.D., to renew or modify Certificate of Registration No. AW8146602 and denied any other pending application for additional registration in California. That denial is part of the same Order that is effective October 21, 2026.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-19230 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/21/2026-19230/john-ramsay-walters-md-decision-and-order)
- [2026-19230 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-21/pdf/2026-19230.pdf)

## Related
- [Previous: 2026-19229, Notice of Formal Determination on Records Release](https://policyrisk.com/federal-register/2026-19229)
- [Next: 2026-19232, Esther Villanueva Valdes, M.D.; Decision and Order](https://policyrisk.com/federal-register/2026-19232)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19230 (as of 2026-09-28).
